GLENMARK PHARMACEUTICALS
Quarterly Results Analysis [Sep2025]
GLENMARK PHARMACEUTICALS Quarterly Results
| Consolidated | Sep2025 UnAudited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
|---|---|---|---|---|---|---|---|---|
| Revenues | ₹6,047 Cr | ₹3,264 Cr | ₹3,256 Cr | ₹3,388 Cr | ₹3,434 Cr | ₹3,244 Cr | ₹3,063 Cr | ₹2,507 Cr |
| Expenses | ₹3,687 Cr | ₹2,684 Cr | ₹2,695 Cr | ₹2,787 Cr | ₹2,832 Cr | ₹2,656 Cr | ₹2,559 Cr | ₹2,715 Cr |
| Operating Income | ₹2,360 Cr | ₹581 Cr | ₹561 Cr | ₹600 Cr | ₹602 Cr | ₹588 Cr | ₹504 Cr | ₹-209 Cr |
| Other Income | ₹201 Cr | ₹26 Cr | ₹12 Cr | ₹31 Cr | ₹39 Cr | ₹31 Cr | ₹773 Cr | ₹45 Cr |
| Interest | ₹66 Cr | ₹58 Cr | ₹67 Cr | ₹52 Cr | ₹48 Cr | ₹40 Cr | ₹149 Cr | ₹134 Cr |
| Depreciation | ₹141 Cr | ₹130 Cr | ₹125 Cr | ₹123 Cr | ₹120 Cr | ₹118 Cr | ₹151 Cr | ₹147 Cr |
| Profit Before Tax | ₹967 Cr | ₹96 Cr | ₹8 Cr | ₹456 Cr | ₹473 Cr | ₹462 Cr | ₹531 Cr | ₹-521 Cr |
| Profit After Tax | ₹610 Cr | ₹47 Cr | ₹4 Cr | ₹348 Cr | ₹354 Cr | ₹340 Cr | ₹-1,239 Cr | ₹-450 Cr |
| EPS | ₹21.63 | ₹1.66 | ₹0.16 | ₹12.33 | ₹12.55 | ₹12.06 | ₹-43.17 | ₹-12.45 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| GLENMARK PHARMACEUTICALS | 1.4% | 6.9% | 26.8% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.7% | 7.4% | -0.1% |
| DIVIS LABORATORIES | -0.1% | -4.8% | 3.3% |
| CIPLA | -0.6% | 1.2% | NA |
| TORRENT PHARMACEUTICALS | 2.2% | 6.3% | 11.4% |
| DR REDDYS LABORATORIES | 1.5% | 6.4% | 4.8% |
| MANKIND PHARMA | -1.9% | -6.8% | -15.7% |
| ZYDUS LIFESCIENCES | -0.8% | -3.9% | -4% |
| LUPIN | 0.5% | 4.7% | 0.5% |
GLENMARK PHARMACEUTICALS Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 85.23 % |
| Y-o-Y | 76.10 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Sep2025 | ₹6,047 Cr | 85.23 | |
| Jun2025 | ₹3,264 Cr | 0.25 | |
| Mar2025 | ₹3,256 Cr | -3.88 | |
| Dec2024 | ₹3,388 Cr | -1.35 | |
| Sep2024 | ₹3,434 Cr | 5.84 | |
| Jun2024 | ₹3,244 Cr | 5.92 | |
| Mar2024 | ₹3,063 Cr | 22.19 | |
| Dec2023 | ₹2,507 Cr | - | |
GLENMARK PHARMACEUTICALS Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 306.45 % |
| Y-o-Y | 292.01 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Sep2025 | ₹2,360 Cr | 306.45 | |
| Jun2025 | ₹581 Cr | 3.47 | |
| Mar2025 | ₹561 Cr | -6.53 | |
| Dec2024 | ₹600 Cr | -0.28 | |
| Sep2024 | ₹602 Cr | 2.33 | |
| Jun2024 | ₹588 Cr | 16.63 | |
| Mar2024 | ₹504 Cr | Positive | |
| Dec2023 | ₹-209 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | 119.46 % |
| Y-o-Y | 122.59 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Sep2025 | 39.02% | 119.46 | |
| Jun2025 | 17.78% | 3.19 | |
| Mar2025 | 17.23% | -2.77 | |
| Dec2024 | 17.72% | 1.08 | |
| Sep2024 | 17.53% | -3.31 | |
| Jun2024 | 18.13% | 10.08 | |
| Mar2024 | 16.47% | Positive | |
| Dec2023 | -8.32% | - | |
GLENMARK PHARMACEUTICALS Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 1,199.54 % |
| Y-o-Y | 72.20 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Sep2025 | ₹610 Cr | 1,199.54 | |
| Jun2025 | ₹47 Cr | 971.46 | |
| Mar2025 | ₹4 Cr | -98.74 | |
| Dec2024 | ₹348 Cr | -1.82 | |
| Sep2024 | ₹354 Cr | 4.19 | |
| Jun2024 | ₹340 Cr | Positive | |
| Mar2024 | ₹-1,239 Cr | Negative | |
| Dec2023 | ₹-450 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | 601.39 % |
| Y-o-Y | -2.13 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Sep2025 | 10.1 % | 601.39 | |
| Jun2025 | 1.44 % | 1,007.69 | |
| Mar2025 | 0.13 % | -98.73 | |
| Dec2024 | 10.27 % | -0.48 | |
| Sep2024 | 10.32 % | -1.62 | |
| Jun2024 | 10.49 % | Positive | |
| Mar2024 | -40.44 % | Negative | |
| Dec2023 | -17.94 % | - | |
GLENMARK PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 1,203.01 % |
| Y-o-Y | 72.35 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Sep2025 | ₹21.63 | 1,203.01 | |
| Jun2025 | ₹1.66 | 937.50 | |
| Mar2025 | ₹0.16 | -98.70 | |
| Dec2024 | ₹12.33 | -1.75 | |
| Sep2024 | ₹12.55 | 4.06 | |
| Jun2024 | ₹12.06 | Positive | |
| Mar2024 | ₹-43.17 | Negative | |
| Dec2023 | ₹-12.45 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD